ALK-Abelló (Denmark)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Denmark), Denmark, covering academic research published from 2000 to 2023. Read More.

Open Access Percentage

49%

Total
Publications

745

Total Open
Publications

368

Total
Citations

25K

Open Access
Percentage

49%

Total
Publications

745

Total Open
Publications

368

Total
Citations

25K

Wikipedia

Website

download

Breakdown

Publisher Open

30%

Both

15%

Other Platform Open

Closed

51%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 21%

Hybrid 26%

No Guarantees 53%

177

Other Platform Open

Domain 64%

Institution 34%

Other Internet 16%

Public 10%

Preprint 4%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	94
Europe PMC	Domain	43
Semantic Scholar	Public	13
Technical University of Denmark, DTU - Technical University of Denmark, DTU Orbit	Institution	10
University College London - UCL Discovery	Institution	8
University of Southern Denmark - University of Southern Denmark Research Portal	Institution	7
DOI	Other Internet	7
Elsevier - Scopus	Other Internet	6
Unknown Repository	Other Internet	5
King's College London - Research Portal	Institution	5

1 / 7

Data updated 7 October 2024